Literature DB >> 15243924

Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.

Edward L Murphy1, Tzong-Hae Lee, Daniel Chafets, Catharie C Nass, Baoguang Wang, Katharine Loughlin, Donna Smith.   

Abstract

BACKGROUND: High human T lymphotropic virus (HTLV)-I provirus load (VL) has been associated with an increased risk of HTLV-associated myelopathy, but little is known about variation in HTLV-I or -II VLs by demographic characteristics and risk behaviors.
METHODS: We measured HTLV-I and HTLV-II VLs in a large cohort of 127 HTLV-I-seropositive and 328 HTLV-II-seropositive former blood donors, by use of real-time polymerase chain reaction using tax primers. Multivariable linear regression was used to control for confounding by relevant covariates.
RESULTS: The mean VLs were 3.28 log(10) copies/10(6) peripheral blood mononuclear cells (PBMCs) (range, 0.5-5.3 log(10) copies/10(6) PBMCs) for HTLV-I and 2.60 log(10) copies/10(6) PBMCs (range, 0.05-5.95 log(10) copies/10(6) PBMCs) for HTLV-II (P<.0001). HTLV-II VLs were higher in those subjects with subtype A infection (mean, 2.82 log(10) copies/10(6) PBMCs) than in those with subtype B infection (mean, 2.29 log(10) copies/10(6) PBMCs) (P=.005). Higher HTLV-I VL was associated with previous receipt of a blood transfusion (P=.04), and lower HTLV-II VL was associated with female sex (P=.007). These associations persisted in virus-specific multivariate linear regression models controlling for potential confounding variables.
CONCLUSIONS: VL was significantly higher in HTLV-I than in HTLV-II infection and was higher in HTLV-II subtype A than in HTLV-II subtype B infection. Chronic HTLV VLs may be related to the infectious dose acquired at the time of infection, with higher VLs following acquisition by blood transfusion and lower VLs following sexual acquisition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15243924     DOI: 10.1086/422398

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion.

Authors:  Priya Kannian; Han Yin; Rami Doueiri; Michael D Lairmore; Soledad Fernandez; Patrick L Green
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Recombinant human T-cell leukemia virus types 1 and 2 Tax proteins induce high levels of CC-chemokines and downregulate CCR5 in human peripheral blood mononuclear cells.

Authors:  Christy S Barrios; Muna Abuerreish; Michael D Lairmore; Laura Castillo; Chou-Zen Giam; Mark A Beilke
Journal:  Viral Immunol       Date:  2011-11-23       Impact factor: 2.257

3.  Human T-lymphotropic virus type 2 subtype b in a patient with chronic neurological disorder.

Authors:  Carolina Rosadas; Ana C P Vicente; Louise Zanella; Mauro J Cabral-Castro; José M Peralta; Marzia Puccioni-Sohler
Journal:  J Neurovirol       Date:  2014-09-03       Impact factor: 2.643

4.  A critical function for B-Raf at multiple stages of myelopoiesis.

Authors:  Tamihiro Kamata; Jing Kang; Tzong-Hae Lee; Leszek Wojnowski; Catrin A Pritchard; Andrew D Leavitt
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

5.  The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.

Authors:  Steven Kleinman; Melissa R King; Michael P Busch; Edward L Murphy; Simone A Glynn
Journal:  Transfus Med Rev       Date:  2012-05-24

6.  Essential Role of Human T Cell Leukemia Virus Type 1 orf-I in Lethal Proliferation of CD4+ Cells in Humanized Mice.

Authors:  Veronica Galli; Christopher C Nixon; Natasa Strbo; Maria Artesi; Maria F de Castro-Amarante; Katherine McKinnon; Dai Fujikawa; Maria Omsland; Robyn Washington-Parks; Laura Romero; Breanna Caruso; Keith Durkin; Sophia Brown; Baktiar Karim; Monica Vaccari; Steve Jacobson; Jerome A Zack; Anne Van den Broeke; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

7.  Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques.

Authors:  Shari N Gordon; Anna R Weissman; Valentina Cecchinato; Claudio Fenizia; Zhong-Min Ma; Tzong-Hae Lee; Lorenzo Zaffiri; Vibeke Andresen; Robyn Washington Parks; Kathryn S Jones; Jean Michel Heraud; Maria Grazia Ferrari; Hye Kyung Chung; David Venzon; Renaud Mahieux; Edward L Murphy; Steven Jacobson; Christopher J Miller; Francis W Ruscetti; Genoveffa Franchini
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

8.  Human T Cell Leukemia Virus Type 1 Infection of the Three Monocyte Subsets Contributes to Viral Burden in Humans.

Authors:  Maria Fernanda de Castro-Amarante; Cynthia A Pise-Masison; Katherine McKinnon; Robyn Washington Parks; Veronica Galli; Maria Omsland; Vibeke Andresen; Raya Massoud; Giovanna Brunetto; Breanna Caruso; David Venzon; Steven Jacobson; Genoveffa Franchini
Journal:  J Virol       Date:  2015-11-25       Impact factor: 5.103

Review 9.  Human T cell leukemia virus type 1 and Zika virus: tale of two reemerging viruses with neuropathological sequelae of public health concern.

Authors:  DeGaulle I Chigbu; Pooja Jain; Brenndan L Crumley; Dip Patel; Zafar K Khan
Journal:  J Neurovirol       Date:  2019-01-28       Impact factor: 3.739

10.  Pathways of cell-cell transmission of HTLV-1.

Authors:  Claudine Pique; Kathryn S Jones
Journal:  Front Microbiol       Date:  2012-10-24       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.